
Founded in 2000 and headquartered in Mountain View, California, Alexza Pharmaceuticals developed and commercialized products based on its proprietary Staccato system — a hand-held single-use inhaler delivering pure drug aerosols to the deep lung for rapid systemic delivery. Its lead commercial product was Adasuve (loxapine), an inhaled antipsychotic for acute agitation associated with schizophrenia or bipolar disorder. Alexza was acquired by Grupo Ferrer Internacional in June 2016 and now operates as part of the Ferrer group.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account